Cluster Analysis of Clinical Remission and Relapse Patterns in Chronic Urticaria: Results from the PREDICT-CU Study
Patients in Clusters 3 and 4 had the lowest clinical remission and highest relapse rates relative to Clusters 1 and 2; additionally, Cluster 4 had higher resource use, more comorbidities, and polypharmacy. These cluster definitions could be used to develop a model to predict patients with relapsing and remitting patterns associated with higher disease burden who might require enhanced disease management.
Authors
- James Signorovitch (ORCID: https://orcid.org/0000-0002-4067-8962)
- Jimmy Royer
- Thomas Severin (ORCID: https://orcid.org/0000-0001-7203-2042)
- Alexander Marsland (ORCID: https://orcid.org/0000-0001-6515-9336)
- Irina Pivneva (ORCID: https://orcid.org/0000-0003-1101-5200)
- Tom Cornwall
- Andrii Danyliv
- Maria‐Magdalena Balp (ORCID: https://orcid.org/0000-0002-8612-7680)
- Ravneet Kaur Kohli (ORCID: https://orcid.org/0009-0001-4450-066X)
- Weily Soong (ORCID: https://orcid.org/0000-0002-2701-7035)
- Kathleen Chen
- Dhaval Patil
Institutions
- Novartis (Switzerland) (CH)
- University of Manchester (GB)
- Novartis (India) (IN)
- Allergy, Asthma and Clinical Research Center (US)
- Novartis (United States) (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1007/s13555-025-01376-4
- Citations
- 2
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 3.34